{"id":"https://openalex.org/W1982910731","doi":"https://doi.org/10.1016/j.jconrel.2014.05.061","title":"Real time Raman imaging to understand dissolution performance of amorphous solid dispersions","display_name":"Real time Raman imaging to understand dissolution performance of amorphous solid dispersions","alternate_titles":[],"publication_year":2014,"publication_date":"2014-06-05","ids":{"openalex":"https://openalex.org/W1982910731","doi":"https://doi.org/10.1016/j.jconrel.2014.05.061","mag":"1982910731","pmid":"https://pubmed.ncbi.nlm.nih.gov/24910191"},"language":"en","primary_location":{"id":"doi:10.1016/j.jconrel.2014.05.061","doi":"https://doi.org/10.1016/j.jconrel.2014.05.061","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.jconrel.2014.05.061","pdf_url":"https://www.sciencedirect.com/science/article/pii/S0168365914003873/pdf","source":{"id":"https://openalex.org/S161954266","display_name":"Journal of Controlled Release","issn_l":"0168-3659","issn":["0168-3659","1873-4995"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Controlled Release","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W1982910731"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://www.sciencedirect.com/science/article/pii/S0168365914003873/pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5039584149","display_name":"Francesco Tres","orcid":"https://orcid.org/0000-0001-6955-654X","observed_orcids":["https://orcid.org/0000-0001-6955-654X"]},"institutions":[{"id":"https://openalex.org/I142263535","display_name":"University of Nottingham","ror":"https://ror.org/01ee9ar58","country_code":"GB","type":"education","lineage":["https://openalex.org/I142263535"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Francesco Tres","raw_affiliation_strings":["School of Pharmacy, Boots Science Building, University of Nottingham, Nottingham NG7 2RD, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"School of Pharmacy, Boots Science Building, University of Nottingham, Nottingham NG7 2RD, United Kingdom","institution_ids":["https://openalex.org/I142263535"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5067361587","display_name":"Kevin Edward Treacher","orcid":"https://orcid.org/0000-0002-8705-3476","observed_orcids":["https://orcid.org/0000-0002-8705-3476"]},"institutions":[{"id":"https://openalex.org/I105036370","display_name":"AstraZeneca (United Kingdom)","ror":"https://ror.org/04r9x1a08","country_code":"GB","type":"company","lineage":["https://openalex.org/I105036370"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Kevin Treacher","raw_affiliation_strings":["Pharmaceutical Development, AstraZeneca, Macclesfield, SK10 2NA, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmaceutical Development, AstraZeneca, Macclesfield, SK10 2NA, United Kingdom","institution_ids":["https://openalex.org/I105036370"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5104086505","display_name":"Jonathan Booth","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I105036370","display_name":"AstraZeneca (United Kingdom)","ror":"https://ror.org/04r9x1a08","country_code":"GB","type":"company","lineage":["https://openalex.org/I105036370"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Jonathan Booth","raw_affiliation_strings":["Pharmaceutical Development, AstraZeneca, Macclesfield, SK10 2NA, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmaceutical Development, AstraZeneca, Macclesfield, SK10 2NA, United Kingdom","institution_ids":["https://openalex.org/I105036370"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5078883486","display_name":"Leslie P. Hughes","orcid":"https://orcid.org/0000-0002-9663-2314","observed_orcids":["https://orcid.org/0000-0002-9663-2314"]},"institutions":[{"id":"https://openalex.org/I105036370","display_name":"AstraZeneca (United Kingdom)","ror":"https://ror.org/04r9x1a08","country_code":"GB","type":"company","lineage":["https://openalex.org/I105036370"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Les P. Hughes","raw_affiliation_strings":["Pharmaceutical Development, AstraZeneca, Macclesfield, SK10 2NA, United Kingdom"],"raw_orcid":"https://orcid.org/0000-0002-9663-2314","affiliations":[{"raw_affiliation_string":"Pharmaceutical Development, AstraZeneca, Macclesfield, SK10 2NA, United Kingdom","institution_ids":["https://openalex.org/I105036370"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064128532","display_name":"Stephen A. C. Wren","orcid":"https://orcid.org/0009-0006-8366-396X","observed_orcids":["https://orcid.org/0009-0006-8366-396X"]},"institutions":[{"id":"https://openalex.org/I105036370","display_name":"AstraZeneca (United Kingdom)","ror":"https://ror.org/04r9x1a08","country_code":"GB","type":"company","lineage":["https://openalex.org/I105036370"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Stephen A.C. Wren","raw_affiliation_strings":["Pharmaceutical Development, AstraZeneca, Macclesfield, SK10 2NA, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmaceutical Development, AstraZeneca, Macclesfield, SK10 2NA, United Kingdom","institution_ids":["https://openalex.org/I105036370"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071752588","display_name":"Jonathan W. Aylott","orcid":"https://orcid.org/0000-0003-1520-5490","observed_orcids":["https://orcid.org/0000-0003-1520-5490"]},"institutions":[{"id":"https://openalex.org/I142263535","display_name":"University of Nottingham","ror":"https://ror.org/01ee9ar58","country_code":"GB","type":"education","lineage":["https://openalex.org/I142263535"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Jonathan W. Aylott","raw_affiliation_strings":["School of Pharmacy, Boots Science Building, University of Nottingham, Nottingham NG7 2RD, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"School of Pharmacy, Boots Science Building, University of Nottingham, Nottingham NG7 2RD, United Kingdom","institution_ids":["https://openalex.org/I142263535"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5038180180","display_name":"J. Burley","orcid":"https://orcid.org/0000-0003-4030-1484","observed_orcids":["https://orcid.org/0000-0003-4030-1484"]},"institutions":[{"id":"https://openalex.org/I142263535","display_name":"University of Nottingham","ror":"https://ror.org/01ee9ar58","country_code":"GB","type":"education","lineage":["https://openalex.org/I142263535"]}],"countries":["GB"],"is_corresponding":true,"raw_author_name":"Jonathan C. Burley","raw_affiliation_strings":["School of Pharmacy, Boots Science Building, University of Nottingham, Nottingham NG7 2RD, United Kingdom. Electronic address: jonathan.burley@nottingham.ac.uk","School of Pharmacy, Boots Science Building, University of Nottingham, Nottingham NG7 2RD, United Kingdom"],"raw_orcid":"https://orcid.org/0000-0003-4030-1484","affiliations":[{"raw_affiliation_string":"School of Pharmacy, Boots Science Building, University of Nottingham, Nottingham NG7 2RD, United Kingdom. Electronic address: jonathan.burley@nottingham.ac.uk","institution_ids":["https://openalex.org/I142263535"]},{"raw_affiliation_string":"School of Pharmacy, Boots Science Building, University of Nottingham, Nottingham NG7 2RD, United Kingdom","institution_ids":["https://openalex.org/I142263535"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5038180180"],"corresponding_institution_ids":["https://openalex.org/I142263535"],"apc_list":{"value":4440,"currency":"USD","value_usd":4440},"apc_paid":{"value":4440,"currency":"USD","value_usd":4440},"fwci":5.2133,"has_fulltext":true,"cited_by_count":83,"citation_normalized_percentile":{"value":0.96870839,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":87,"max":99},"biblio":{"volume":"188","issue":null,"first_page":"53","last_page":"60"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10256","display_name":"Drug Solubulity and Delivery Systems","score":0.9951000213623047,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10256","display_name":"Drug Solubulity and Delivery Systems","score":0.9951000213623047,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11881","display_name":"Crystallization and Solubility Studies","score":0.0010000000474974513,"subfield":{"id":"https://openalex.org/subfields/2505","display_name":"Materials Chemistry"},"field":{"id":"https://openalex.org/fields/25","display_name":"Materials Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10920","display_name":"Advanced Drug Delivery Systems","score":0.00039999998989515007,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/amorphous-solid-dispersions","display_name":"amorphous solid dispersions","score":0.9950000047683716},{"id":"https://openalex.org/keywords/raman-imaging","display_name":"Raman imaging","score":0.6349999904632568},{"id":"https://openalex.org/keywords/felodipine","display_name":"felodipine","score":0.7900000214576721},{"id":"https://openalex.org/keywords/dissolution-mechanism","display_name":"dissolution mechanism","score":0.5820000171661377},{"id":"https://openalex.org/keywords/drug-polymer-interactions","display_name":"drug-polymer interactions","score":0.5860000252723694},{"id":"https://openalex.org/keywords/poorly-water-soluble-drugs","display_name":"poorly water-soluble drugs","score":0.9110000133514404}],"concepts":[{"id":"https://openalex.org/C88380143","wikidata":"https://www.wikidata.org/wiki/Q416674","display_name":"Dissolution","level":2,"score":0.9259177446365356},{"id":"https://openalex.org/C40003534","wikidata":"https://www.wikidata.org/wiki/Q862228","display_name":"Raman spectroscopy","level":2,"score":0.8098021149635315},{"id":"https://openalex.org/C56052488","wikidata":"https://www.wikidata.org/wiki/Q103382","display_name":"Amorphous solid","level":2,"score":0.7787675857543945},{"id":"https://openalex.org/C177562468","wikidata":"https://www.wikidata.org/wiki/Q182893","display_name":"Dispersion (optics)","level":2,"score":0.5863292217254639},{"id":"https://openalex.org/C14029885","wikidata":"https://www.wikidata.org/wiki/Q5282807","display_name":"Dissolution testing","level":4,"score":0.5523727536201477},{"id":"https://openalex.org/C155574463","wikidata":"https://www.wikidata.org/wiki/Q170731","display_name":"Solubility","level":2,"score":0.5210903882980347},{"id":"https://openalex.org/C77281830","wikidata":"https://www.wikidata.org/wiki/Q718608","display_name":"Dosage form","level":2,"score":0.4736389219760895},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.4657370150089264},{"id":"https://openalex.org/C42360764","wikidata":"https://www.wikidata.org/wiki/Q83588","display_name":"Chemical engineering","level":1,"score":0.4457872807979584},{"id":"https://openalex.org/C45904493","wikidata":"https://www.wikidata.org/wiki/Q912807","display_name":"Active ingredient","level":2,"score":0.4420406222343445},{"id":"https://openalex.org/C2780648877","wikidata":"https://www.wikidata.org/wiki/Q420644","display_name":"Felodipine","level":3,"score":0.4278518855571747},{"id":"https://openalex.org/C113196181","wikidata":"https://www.wikidata.org/wiki/Q485223","display_name":"Analytical Chemistry (journal)","level":2,"score":0.4173544943332672},{"id":"https://openalex.org/C192562407","wikidata":"https://www.wikidata.org/wiki/Q228736","display_name":"Materials science","level":0,"score":0.4070422053337097},{"id":"https://openalex.org/C43617362","wikidata":"https://www.wikidata.org/wiki/Q170050","display_name":"Chromatography","level":1,"score":0.3711755871772766},{"id":"https://openalex.org/C178790620","wikidata":"https://www.wikidata.org/wiki/Q11351","display_name":"Organic chemistry","level":1,"score":0.18762508034706116},{"id":"https://openalex.org/C2781430271","wikidata":"https://www.wikidata.org/wiki/Q278760","display_name":"Biopharmaceutics Classification System","level":3,"score":0.0985199511051178},{"id":"https://openalex.org/C120665830","wikidata":"https://www.wikidata.org/wiki/Q14620","display_name":"Optics","level":1,"score":0.09342426061630249},{"id":"https://openalex.org/C126838900","wikidata":"https://www.wikidata.org/wiki/Q77604","display_name":"Radiology","level":1,"score":0.0},{"id":"https://openalex.org/C60644358","wikidata":"https://www.wikidata.org/wiki/Q128570","display_name":"Bioinformatics","level":1,"score":0.0},{"id":"https://openalex.org/C84393581","wikidata":"https://www.wikidata.org/wiki/Q82642","display_name":"Blood pressure","level":2,"score":0.0},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.0},{"id":"https://openalex.org/C127413603","wikidata":"https://www.wikidata.org/wiki/Q11023","display_name":"Engineering","level":0,"score":0.0},{"id":"https://openalex.org/C121332964","wikidata":"https://www.wikidata.org/wiki/Q413","display_name":"Physics","level":0,"score":0.0},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.0}],"mesh":[{"descriptor_ui":"D000959","descriptor_name":"Antihypertensive Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000959","descriptor_name":"Antihypertensive Agents","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D003460","descriptor_name":"Crystallization","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004339","descriptor_name":"Drug Compounding","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011759","descriptor_name":"Pyrrolidines","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D012995","descriptor_name":"Solubility","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013059","descriptor_name":"Spectrum Analysis, Raman","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":true},{"descriptor_ui":"D014677","descriptor_name":"Pharmaceutical Vehicles","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D014753","descriptor_name":"Vinyl Compounds","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D014961","descriptor_name":"X-Ray Diffraction","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015736","descriptor_name":"Felodipine","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D015736","descriptor_name":"Felodipine","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D033362","descriptor_name":"Powder Diffraction","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":5,"locations":[{"id":"doi:10.1016/j.jconrel.2014.05.061","doi":"https://doi.org/10.1016/j.jconrel.2014.05.061","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.jconrel.2014.05.061","pdf_url":"https://www.sciencedirect.com/science/article/pii/S0168365914003873/pdf","source":{"id":"https://openalex.org/S161954266","display_name":"Journal of Controlled Release","issn_l":"0168-3659","issn":["0168-3659","1873-4995"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Controlled Release","raw_type":"journal-article"},{"id":"pmh:oai:https://nottingham-repository.worktribe.com/:733887","doi":null,"is_oa":true,"landing_page_url":"https://nottingham-repository.worktribe.com/output/733887","pdf_url":"https://nottingham-repository.worktribe.com/preview/733907/1-s2.0-S0168365914003873-main%281%29.pdf","source":{"id":"https://openalex.org/S4306402483","display_name":"Repository@Nottingham (University of Nottingham)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I142263535","host_organization_name":"University of Nottingham","host_organization_lineage":["https://openalex.org/I142263535"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":null,"raw_type":"Journal Article"},{"id":"pmid:24910191","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/24910191","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of controlled release : official journal of the Controlled Release Society","raw_type":"Journal Article"},{"id":"pmh:oai:nottingham-repository.worktribe.com:733887","doi":null,"is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.jconrel.2014.05.061","pdf_url":null,"source":{"id":"https://openalex.org/S4306402483","display_name":"Repository@Nottingham (University of Nottingham)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I142263535","host_organization_name":"University of Nottingham","host_organization_lineage":["https://openalex.org/I142263535"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":null,"raw_type":"Journal Article"},{"id":"pmh:oai:eprints.nottingham.ac.uk:37564","doi":null,"is_oa":true,"landing_page_url":"http://eprints.nottingham.ac.uk/37564/","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"Article"}],"best_oa_location":{"id":"doi:10.1016/j.jconrel.2014.05.061","doi":"https://doi.org/10.1016/j.jconrel.2014.05.061","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.jconrel.2014.05.061","pdf_url":"https://www.sciencedirect.com/science/article/pii/S0168365914003873/pdf","source":{"id":"https://openalex.org/S161954266","display_name":"Journal of Controlled Release","issn_l":"0168-3659","issn":["0168-3659","1873-4995"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Controlled Release","raw_type":"journal-article"},"sustainable_development_goals":[],"study_designs":[],"awards":[{"id":"https://openalex.org/G2882476434","display_name":"From Targeted Therapeutics to Next-Generation Medicines","funder_award_id":"EP/I01375X/1","funder_id":"https://openalex.org/F4320334627","funder_display_name":"Engineering and Physical Sciences Research Council"},{"id":"https://openalex.org/G5199562786","display_name":null,"funder_award_id":"1091706","funder_id":"https://openalex.org/F4320334627","funder_display_name":"Engineering and Physical Sciences Research Council"}],"funders":[{"id":"https://openalex.org/F4320307770","display_name":"AstraZeneca","ror":"https://ror.org/04r9x1a08"},{"id":"https://openalex.org/F4320334627","display_name":"Engineering and Physical Sciences Research Council","ror":"https://ror.org/0439y7842"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W1982910731.pdf","grobid_xml":"https://content.openalex.org/works/W1982910731.grobid-xml"},"referenced_works_count":31,"referenced_works":["https://openalex.org/W1543696264","https://openalex.org/W1590254871","https://openalex.org/W1967682977","https://openalex.org/W1967935934","https://openalex.org/W1972559099","https://openalex.org/W1974487406","https://openalex.org/W1976964681","https://openalex.org/W1998970318","https://openalex.org/W2023152055","https://openalex.org/W2025829497","https://openalex.org/W2026023226","https://openalex.org/W2026662023","https://openalex.org/W2037821082","https://openalex.org/W2039499240","https://openalex.org/W2044594845","https://openalex.org/W2047881579","https://openalex.org/W2048644610","https://openalex.org/W2049439891","https://openalex.org/W2065836831","https://openalex.org/W2069580393","https://openalex.org/W2071060910","https://openalex.org/W2075179133","https://openalex.org/W2082753849","https://openalex.org/W2084590307","https://openalex.org/W2107714322","https://openalex.org/W2141807666","https://openalex.org/W2149111315","https://openalex.org/W2169796533","https://openalex.org/W2335434301","https://openalex.org/W2479931273","https://openalex.org/W2582743722"],"related_works":["https://openalex.org/W2279669423","https://openalex.org/W2261208107","https://openalex.org/W2333296712","https://openalex.org/W2094133489","https://openalex.org/W2326962754","https://openalex.org/W2084590307","https://openalex.org/W2039499240","https://openalex.org/W7199125995","https://openalex.org/W1525796979","https://openalex.org/W2169796533"],"abstract_inverted_index":{"We":[0,42],"have":[1,43,90],"employed":[2,45],"for":[3],"the":[4,24,38,57,64,104,108,112,118,129,134,145,149,164,202,204,214,239],"first":[5],"time":[6,21],"Raman":[7,141,183,223],"spectroscopic":[8],"imaging":[9,224],"along":[10,185],"with":[11,32,103,133,186],"multi-variate":[12],"curve":[13],"resolution":[14],"(MCR)":[15],"analysis":[16],"to":[17,54,178,208,232],"investigate":[18],"in":[19,73,82,128],"real":[20],"and":[22,70,96,126,138,174,218],"in-situ":[23],"dissolution":[25,50,65,119,136],"mechanisms":[26],"that":[27,124,139,148,194],"underpin":[28],"amorphous":[29,231],"solid":[30],"dispersions,":[31],"data":[33],"being":[34],"collected":[35],"directly":[36],"from":[37,201,230],"dosage":[39,240],"form":[40],"itself.":[41],"also":[44],"a":[46,83,209],"novel":[47],"rotating":[48],"disk":[49],"rate":[51,137],"(RDDR)":[52],"methodology":[53],"track,":[55],"through":[56],"use":[58],"of":[59,67,78,86,94,106,110,114,171,199,221,228],"high-performance":[60],"liquid":[61],"chromatography":[62],"(HPLC),":[63],"trends":[66],"both":[68,172],"drug":[69,92,205],"polymer":[71],"simultaneously":[72],"multi-component":[74],"systems.":[75],"Two":[76],"formulations":[77],"poorly":[79],"water-soluble":[80,161],"felodipine":[81,125,173,234],"polymeric":[84],"matrix":[85],"copovidone":[87,127,175,200],"VA64":[88],"which":[89],"different":[91,226,236],"loadings":[93],"5%":[95,130],"50%":[97,165],"w/w":[98],"were":[99,176],"used":[100],"as":[101,153],"models":[102],"aim":[105],"studying":[107],"effects":[109],"increasing":[111],"amount":[113],"active":[115],"ingredient":[116],"on":[117,213],"performance.":[120],"It":[121],"was":[122],"found":[123,177],"dispersion":[131],"dissolve":[132,152],"same":[135],"no":[140],"spectral":[142],"changes":[143],"accompanied":[144],"dissolution,":[146],"indicating":[147],"two":[150],"components":[151],"single":[154],"entity,":[155],"whose":[156],"behaviour":[157],"is":[158],"dominated":[159],"by":[160],"copovidone.":[162],"For":[163],"drug-loaded":[166],"dispersion,":[167],"partial":[168],"RDDR":[169],"values":[170],"be":[179],"extremely":[180],"low.":[181],"MCR":[182],"maps":[184],"classical":[187],"Raman/X-ray":[188],"powder":[189],"diffraction":[190],"(XRPD)":[191],"characterisation":[192],"revealed":[193,225],"after":[195],"an":[196],"initial":[197],"loss":[198],"extrudate":[203],"re-crystallises,":[206],"pointing":[207],"release":[210],"dynamics":[211],"dependent":[212],"low":[215],"water":[216],"solubility":[217],"high":[219],"hydrophobicity":[220],"felodipine.":[222],"rates":[227],"transition":[229],"crystalline":[233],"at":[235],"locations":[237],"within":[238],"form.":[241]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W1982910731","counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":3},{"year":2024,"cited_by_count":8},{"year":2023,"cited_by_count":5},{"year":2022,"cited_by_count":5},{"year":2021,"cited_by_count":8},{"year":2020,"cited_by_count":8},{"year":2019,"cited_by_count":11},{"year":2018,"cited_by_count":5},{"year":2017,"cited_by_count":7},{"year":2016,"cited_by_count":10},{"year":2015,"cited_by_count":10},{"year":2014,"cited_by_count":1}],"updated_date":"2026-11-17T12:49:18.490984","created_date":"2016-06-24T00:00:00"}
